Wall St Engine
Here’s what analysts are saying after the $GOOGL selloff tied to Eddy Cue’s AI search comments:
Wells Fargo (Equal Weight, PT $175): "The time to debate changes in search behavior has come to a close... Expect Google to more aggressively exploit its distribution advantage, pushing AI Search in the main search bar. Expect disruption to follow, but better sooner than later."
Bank of America (Buy, PT $200): "Apple commentary reflects changing search landscape; queries are still growing." Cue noted “increasing usage of new Gen-AI platforms,” and that “AI search providers could eventually replace traditional engines like Google.”
Citi (Buy, PT $200): "Competition in the Search landscape is at its highest level in potentially…ever." But: "We are focused on GOOGL’s newer products gaining GenAI share—Gemini, AI Overviews & AI Mode." Also highlights “AI Max”, enabling “2X higher conversion rate at 31% lower cost” for clients like L'Oréal.
Morgan Stanley (Overweight, PT $185): "Sentiment has (again) troughed. Shares now trade at 15x FY26 $10 EPS estimate—a trough multiple and tactically a strong buying opportunity."
tweet
Here’s what analysts are saying after the $GOOGL selloff tied to Eddy Cue’s AI search comments:
Wells Fargo (Equal Weight, PT $175): "The time to debate changes in search behavior has come to a close... Expect Google to more aggressively exploit its distribution advantage, pushing AI Search in the main search bar. Expect disruption to follow, but better sooner than later."
Bank of America (Buy, PT $200): "Apple commentary reflects changing search landscape; queries are still growing." Cue noted “increasing usage of new Gen-AI platforms,” and that “AI search providers could eventually replace traditional engines like Google.”
Citi (Buy, PT $200): "Competition in the Search landscape is at its highest level in potentially…ever." But: "We are focused on GOOGL’s newer products gaining GenAI share—Gemini, AI Overviews & AI Mode." Also highlights “AI Max”, enabling “2X higher conversion rate at 31% lower cost” for clients like L'Oréal.
Morgan Stanley (Overweight, PT $185): "Sentiment has (again) troughed. Shares now trade at 15x FY26 $10 EPS estimate—a trough multiple and tactically a strong buying opportunity."
tweet
Offshore
Photo
Investing visuals
$SHOP Q1 Earnings 🚨
• Revenue $2.36B vs Est. $2.33B
• EPS $0.25 vs Est. $0.26
• GMV $74.8B vs Est. $74.8B
Shares are down -9% pre-market https://t.co/rDIluj049D
tweet
$SHOP Q1 Earnings 🚨
• Revenue $2.36B vs Est. $2.33B
• EPS $0.25 vs Est. $0.26
• GMV $74.8B vs Est. $74.8B
Shares are down -9% pre-market https://t.co/rDIluj049D
tweet
Wall St Engine
The EU 🇪🇺 just dropped a draft list targeting $107B worth of U.S. goods with potential tariffs if trade talks break down—including planes, cars, bourbon, meat, chemicals, metals, and beer. They’re also eyeing $4.4B in export curbs on scrap metals and chemicals. EU says it’s “fully committed” to finding a deal, but clearly preparing to hit back.
tweet
The EU 🇪🇺 just dropped a draft list targeting $107B worth of U.S. goods with potential tariffs if trade talks break down—including planes, cars, bourbon, meat, chemicals, metals, and beer. They’re also eyeing $4.4B in export curbs on scrap metals and chemicals. EU says it’s “fully committed” to finding a deal, but clearly preparing to hit back.
tweet
Offshore
Photo
Wall St Engine
Bill Gates is pledging 99% of his $168B fortune to the Gates Foundation, which will now close in 2045.
That’s ~$107B more going toward global health, education, and poverty over the next 20 years. The foundation will spend ~$200B in total before winding down. https://t.co/ofyoJNR1LN
tweet
Bill Gates is pledging 99% of his $168B fortune to the Gates Foundation, which will now close in 2045.
That’s ~$107B more going toward global health, education, and poverty over the next 20 years. The foundation will spend ~$200B in total before winding down. https://t.co/ofyoJNR1LN
tweet
Wall St Engine
$NVAX | Novavax Q1'25 Earnings Highlights
🔹 Revenue: $667M vs. $344M est. 🟢
🔹 EPS: $2.93 vs. $0.71 est. 🟢
Guidance:
🔹 FY25 Revenue: $975M–$1.025B (Est. $724M) 🟢
🔹 FY25 R&D + SG&A: $475M–$525M (Reiterated)
🔹 No guidance yet for Sanofi royalties/supply sales
Highlights:
🔸 FDA feedback suggests COVID-19 BLA approvable upon PMC alignment
🔸 $175M milestone from Sanofi triggered by BLA approval
🔸 SHIELD-Utah study: ~39% fewer side effects vs. mRNA vaccine
🔸 Expanded partnership with Takeda; $20M upfront + milestones
🔸 Raised FY25 revenue framework from $300–$350M to $975M–$1.025B
🔸 $519M net income in Q1; $603M recognized from terminated APAs
tweet
$NVAX | Novavax Q1'25 Earnings Highlights
🔹 Revenue: $667M vs. $344M est. 🟢
🔹 EPS: $2.93 vs. $0.71 est. 🟢
Guidance:
🔹 FY25 Revenue: $975M–$1.025B (Est. $724M) 🟢
🔹 FY25 R&D + SG&A: $475M–$525M (Reiterated)
🔹 No guidance yet for Sanofi royalties/supply sales
Highlights:
🔸 FDA feedback suggests COVID-19 BLA approvable upon PMC alignment
🔸 $175M milestone from Sanofi triggered by BLA approval
🔸 SHIELD-Utah study: ~39% fewer side effects vs. mRNA vaccine
🔸 Expanded partnership with Takeda; $20M upfront + milestones
🔸 Raised FY25 revenue framework from $300–$350M to $975M–$1.025B
🔸 $519M net income in Q1; $603M recognized from terminated APAs
tweet
Offshore
Photo
Wall St Engine
Coinbase $COIN is buying Deribit—the world’s top bitcoin and ether options exchange—for $2.9B in cash and stock. It’s Coinbase’s biggest deal yet. https://t.co/OTyxZozpRX
tweet
Coinbase $COIN is buying Deribit—the world’s top bitcoin and ether options exchange—for $2.9B in cash and stock. It’s Coinbase’s biggest deal yet. https://t.co/OTyxZozpRX
tweet
Offshore
Photo